Antitumor activity of a combination of trastuzumab (Herceptin) and oral fluoropyrimidine S-1 on human epidermal growth factor receptor 2-overexpressing pancreatic cancer
2013 ◽
Vol 13
(1)
◽
pp. 90-100
◽
2001 ◽
Vol 44
(17)
◽
pp. 2719-2734
◽
2010 ◽
Vol 16
(7)
◽
pp. 2085-2094
◽
2020 ◽
Vol 39
(4)
◽
pp. 123-128
2017 ◽
Vol 36
(6)
◽
pp. 287-290
◽